Tradewinds Capital Management »

Crispr Therapeutics shares owned by Tradewinds Capital Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Tradewinds Capital Management from 13F filings

Historical chart of Tradewinds Capital Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Tradewinds Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Tradewinds Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $48k 710 68.16
2023-12-31 $44k 710 62.60
2023-09-30 $32k 710 45.39
2023-06-30 $6.2k 110 56.15
2023-03-31 $5.0k 110 45.24
2022-12-31 $4.7k 115 40.65
2022-09-30 $8.0k 115 69.57
2022-06-30 $7.0k 110 63.64
2022-03-31 $7.0k 110 63.64
2021-12-31 $8.0k 110 72.73
2021-09-30 $7.0k 60 116.67
2021-06-30 $10k 60 166.67
2021-03-31 $7.0k 60 116.67
2020-12-31 $9.0k 60 150.00
2020-09-30 $5.0k 60 83.33
2020-06-30 $4.0k 60 66.67
2020-03-31 $3.0k 60 50.00
2019-12-31 $5.0k 75 66.67
2019-06-30 $3.0k 65 46.15
2019-03-31 $3.0k 85 35.29